VENN STRATEGIES

Lobbying for TRIS PHARMA, INC. · Biopharmaceutical company

Filing 3rd Quarter - Termination

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Representation ended

Aug 15, 2025

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Policy activities related to treatment of ADHD.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.